Photo: Tatiana | Pixabay
At the University of Hawaii School of Medicine, researchers and industry partner Soligenix are designing a vaccine that can withstand higher temperatures. Temperature remains to be one of the main bottlenecks for vaccine distribution in low-income countries and a cause for half of vaccines being wasted globally. The UH research team is hoping to introduce another vaccine on the market called CiVax to circumvent temperature complications. The vaccine features freeze-dried viral protein allowing the protein to withstand higher temperatures. The vaccine ends up looking like a "little white muffin," says Axel Lehrer, project leader. The research team generated successful results in cell culture and primates, but viability in humans is not yet known due to lack of funding at this time.
|
|
More:
